PMH41 COST-UTILITY ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN MAJOR DEPRESSIVE DISORDER IN ISRAEL
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72918-7
https://www.valueinhealthjournal.com/article/S1098-3015(11)72918-7/fulltext
Title :
PMH41 COST-UTILITY ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN MAJOR DEPRESSIVE DISORDER IN ISRAEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72918-7&doi=10.1016/S1098-3015(11)72918-7
First page :
A453
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1077